Explore Business Standard
Don’t miss the latest developments in business and finance.
Nearly 20 years after Caribbean islanders sued to hold the French government criminally responsible for the banana industry's extended use of a banned pesticide in Martinique and Guadeloupe, a panel of judges has dismissed their case, ruling that it's too hard to determine who's to blame for acts committed so long ago. The judges in Paris described the use of chlordecone from 1973-1993 as a scandalous environmental attack whose human, economic and social consequences affect and will affect for many years the daily life of the inhabitants of the two French Caribbean islands. But they also asserted that even in the 1990s, scientists had not established links between chlordecone and illnesses in people. How dare they write such a historical and scientific untruth, Christophe Lguevaques, an attorney involved in the case, said in a statement issued on Thursday. Chlordecone, also known as kepone, was patented in the 1950s by scientists working for Allied Chemical, a US company based in N
The initial public offer of India Pesticides Limited was subscribed 29 times on the closing day of the subscription on Friday. The Rs 800-crore IPO received bids for 56,07,11,650 shares against 1,93,10,345 shares on offer, as per NSE data. Qualified Institutional Buyers (QIBs) category was subscribed 42.95 times, non-institutional investors 51.88 times, and those for Retail Individual Investors(RIIs) 11.30 times. The initial public offer (IPO) comprised a fresh issue of Rs 100 crore and an offer for sale of Rs 700 crore. The offer was in a price range of Rs 290-296 per share. On Tuesday, India Pesticides raised Rs 240 crore from anchor investors. Proceeds from the fresh issue would be used towards funding the working capital requirements and general corporate purposes. India Pesticides is an R&D-focused agrochemical technical company, which has growing formulations business in herbicides, insecticides, and fungicide segments. It also manufactures active pharmaceutical ...